For example, in the development of cancer diagnostics, OR51E2 has been described as a potential biomarker for the identification of prostate cancer due to its upregulation in prostate carcinoma cells compared to healthy prostate epithelial cells (Xu et al., 2000; Xia et al., 2001). The gene discussed is OR51E2; the disease is prostate carcinoma.